Russell Investments Group, Ltd.

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1692234 Seattle, WA

Position in DNTH

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$13,981,651

+$3,150,517 QoQ

Shares Held

143,431

+11.1% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#69

of 269 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 93% Shared 0% None 7%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. DNTH ranks #30 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,981,651	143,431	+11.1%	Shares	Defined	2026-08-06
2026-03-31	$10,831,134	129,065	+46.2%	Shares	Defined	2026-05-08
2025-12-31	$3,638,388	88,289	+5356.7%	Shares	Defined	2026-02-17
2025-09-30	$63,668	1,618	—	Shares	Defined	2025-11-13
2021-12-31 MGTA	—	2,148	0.0%	Shares	Defined	2022-01-21
2021-09-30 MGTA	—	2,148	-65.8%	Shares	Defined	2021-11-08
2021-06-30 MGTA	—	6,289	-82.1%	Shares	Sole	2021-08-04
2021-03-31 MGTA	—	35,039	-55.4%	Shares	Defined	2021-05-10
2020-12-31 MGTA	—	78,560	-12.5%	Shares	Defined	2021-02-08
2020-09-30 MGTA	—	89,756	+103.4%	Shares	Sole	2020-11-09
2020-06-30 MGTA	—	44,123	+3.2%	Shares	Sole	2020-08-05
2020-03-31 MGTA	—	42,767	—	Shares	Defined	2020-05-06
No filing history on record for this holder in this stock.